OBJECTIVES: Upon completion of this activity, the participant should be able to: (1) Identify drugs that may lead to renal disease, (2) Treat renal disease associated with drug induced nephrotoxicity, (3) Avoid drugs related to nephrotoxicity.
FACULTY DISCLOSURE: Sandeep Shori, DO has disclosed he received an honorarium as a speaker for Fresenius. All relevant financial relationships have been resolved.
PLANNERS DISCLOSURES: Jay Herd, MD does not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.
ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For information please contact Mary Biggers at Mary.Biggers@BSWHealth.org
- 1.00 AMA PRA Category 1 Credit™The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 1.00 Attendance